GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ansell Ltd (OTCPK:ANSLF) » Definitions » YoY Rev. per Sh. Growth

Ansell (Ansell) YoY Rev. per Sh. Growth : -5.23% (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Ansell YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Ansell's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 was -5.23%.

Ansell's Revenue per Share for the six months ended in Dec. 2023 was $6.23.


Ansell YoY Rev. per Sh. Growth Historical Data

The historical data trend for Ansell's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ansell YoY Rev. per Sh. Growth Chart

Ansell Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.72 11.98 27.67 -2.25 -14.47

Ansell Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.24 -12.14 -16.03 -12.79 -5.23

Ansell YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Ansell's YoY Rev. per Sh. Growth for the fiscal year that ended in Jun. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Jun. 2023 )
=(Revenue per Share (A: Jun. 2023 )-Revenue per Share (A: Jun. 2022 ))/ | Revenue per Share (A: Jun. 2022 ) |
=(13.024-15.228)/ | 15.228 |
=-14.47 %

Ansell's YoY Rev. per Sh. Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (Q: Dec. 2023 )
=(Revenue per Share (Q: Dec. 2023 )-Revenue per Share (Q: Dec. 2022 )) / | Revenue per Share (Q: Dec. 2022 )) |
=(6.231-6.575)/ | 6.575 |
=-5.23 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ansell YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Ansell's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Ansell (Ansell) Business Description

Traded in Other Exchanges
Address
678 Victoria Street, Level 3, Richmond, VIC, AUS, 3121
Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 60% of revenue and 70% of operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly across more than 100 countries. In fiscal 2022, Ansell earned 45% of revenue in North America, 33% from Europe, Middle East and Africa, 14% across Asia-Pacific and the remaining 8% in Latin America.

Ansell (Ansell) Headlines

From GuruFocus

Ansell Growing Through M&A

By Holmes Osborne, CFA Holmes Osborne, CFA 02-22-2019

PPE Manufacturer Ansell Still Trading at a Nice Valuation

By Holmes Osborne, CFA Holmes Osborne, CFA 05-19-2021

Australian Ansell Expanding Into Medical Supplies

By Holmes Osborne, CFA Holmes Osborne, CFA 02-15-2017